These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8828254)

  • 1. Effect of nebulized fenoterol on spirometry, dyspnea sensation changes during exercise in patients with chronic obstructive pulmonary disease.
    Chiang LL; Yu CT; Kuo HP
    Changgeng Yi Xue Za Zhi; 1996 Jun; 19(2):129-34. PubMed ID: 8828254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
    Belman MJ; Botnick WC; Shin JW
    Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease.
    O'Donnell DE; Lam M; Webb KA
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1557-65. PubMed ID: 9817708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
    Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP
    Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of aerosol oxitropium bromide and fenoterol on maximal exercise capacity in chronic obstructive pulmonary disease and their correlation with air flow during exercise and with parameters of maximal exercise].
    Suruda T; Nakamura H; Kobayashi H; Uetani K; Nishio M; Higashimoto Y; Funasako M; Ohata M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Sep; 31(9):1089-95. PubMed ID: 8255017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual results of treatment of COPD with low doses of fenoterol compared with treatment with ipratropium bromide.
    Hodzhev B; Kostianev S; Todorov I; Belev G; Kartev S
    Folia Med (Plovdiv); 1999; 41(4):46-52. PubMed ID: 10786204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventilation-perfusion response after fenoterol in hypoxemic patients with stable COPD.
    Viegas CA; Ferrer A; Montserrat JM; Barberà JA; Roca J; Rodriguez-Roisin R
    Chest; 1996 Jul; 110(1):71-7. PubMed ID: 8681669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of domiciliary nebulizers in managing patients with severe COPD.
    Eiser N; Angus K; McHale S
    Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease.
    O'Donnell DE; Lam M; Webb KA
    Am J Respir Crit Care Med; 1999 Aug; 160(2):542-9. PubMed ID: 10430726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of nebulised isotonic saline and terbutaline on breathlessness in severe chronic obstructive pulmonary disease (COPD).
    Poole PJ; Brodie SM; Stewart JM; Black PN
    Aust N Z J Med; 1998 Jun; 28(3):322-6. PubMed ID: 9673744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease.
    Hay JG; Stone P; Carter J; Church S; Eyre-Brook A; Pearson MG; Woodcock AA; Calverley PM
    Eur Respir J; 1992 Jun; 5(6):659-64. PubMed ID: 1628722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation.
    Morrison JF; Jones PC; Muers MF
    Eur Respir J; 1992 Apr; 5(4):424-9. PubMed ID: 1532940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procaterol metered aerosol in patients with chronic obstructive pulmonary disease.
    Baronti A; Lelli M; Manini G; Verdiani P
    Int J Clin Pharmacol Res; 1987; 7(5):363-8. PubMed ID: 2889678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of salmeterol and ipratropium bromide on exercise performance and breathlessness in patients with stable chronic obstructive pulmonary disease.
    Patakas D; Andreadis D; Mavrofridis E; Argyropoulou P
    Respir Med; 1998 Sep; 92(9):1116-21. PubMed ID: 9926165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate.
    Mahler DA; Waterman LA; Ward J; Gifford AH
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):103-9. PubMed ID: 23745526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation.
    Mak VH; Bugler JR; Roberts CM; Spiro SG
    Thorax; 1993 Jan; 48(1):33-8. PubMed ID: 8434350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease.
    Marin JM; Carrizo SJ; Gascon M; Sanchez A; Gallego B; Celli BR
    Am J Respir Crit Care Med; 2001 May; 163(6):1395-9. PubMed ID: 11371407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of ipratropium bromide on lung dynamic hyperinflation in patients with chronic obstructive lung disease].
    Jorquera J; Díaz O; Lisboa C
    Rev Med Chil; 2003 Jun; 131(6):605-12. PubMed ID: 12942587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.